361 Capital »

Cytomx Therapeutics shares owned by 361 Capital

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by 361 Capital from 13F filings

Historical chart of 361 Capital investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by 361 Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by 361 Capital

Quarter filed Position value Share count Share price at filing
2020-06-30 $671k 81k 8.33

More positions owned by 361 Capital

Schwab International Equity Et Intl Eqty Etf (SCHF)
Schwab U.s. Tips Etf Us Tips Etf (SCHP)
Schwab Emerging Markets Equity Emrg Mkteq Etf (SCHE)
Spdr Blmbg Barclays Inv Grd Fl Blomberg Brc Inv (FLRN)
Schwab U.s. Large-cap Etf Us Lrg Cap Etf (SCHX)
Schwab U.s. Reit Etf Us Reit Etf (SCHH)
Schwab U.s. Mid Cap Etf Us Mid-cap Etf (SCHM)
Cadence Design Systems (CDNS)
Deckers Outdoor Corporation (DECK)
Berry Plastics (BERY)
Howmet Aerospace (HWM)
Clorox Company (CLX)
Lear Corp Com Cl A (LEA)
AutoZone (AZO)
Dish Network Corp Cl A

View all positions for 361 Capital

Top funds holding Cytomx Therapeutics

BVF
Tang Capital Management
Vanguard Group
Laurion Capital Management
Susquehanna International
Bronte Capital Management Pty
Millennium Management
Jacobs Levy Equity Management
Assenagon Asset Management
Marshall Wace
BBK Capital Partners
Toroso Investments
Connor, Clark & Lunn Investment Management
Citadel Advisors
Bank of New York Mellon

View all funds holding Cytomx Therapeutics